IT1118900B - PHARMACEUTICAL COMPOSITION CONTAINING CEPHALOSPORIN FOR RECTAL ADMINISTRATION - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING CEPHALOSPORIN FOR RECTAL ADMINISTRATION

Info

Publication number
IT1118900B
IT1118900B IT49844/79A IT4984479A IT1118900B IT 1118900 B IT1118900 B IT 1118900B IT 49844/79 A IT49844/79 A IT 49844/79A IT 4984479 A IT4984479 A IT 4984479A IT 1118900 B IT1118900 B IT 1118900B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
rectal administration
containing cephalosporin
cephalosporin
Prior art date
Application number
IT49844/79A
Other languages
Italian (it)
Other versions
IT7949844A0 (en
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of IT7949844A0 publication Critical patent/IT7949844A0/en
Application granted granted Critical
Publication of IT1118900B publication Critical patent/IT1118900B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
IT49844/79A 1978-07-25 1979-07-24 PHARMACEUTICAL COMPOSITION CONTAINING CEPHALOSPORIN FOR RECTAL ADMINISTRATION IT1118900B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9000178A JPS5517342A (en) 1978-07-25 1978-07-25 Cephalosporin composition for rectal administaration

Publications (2)

Publication Number Publication Date
IT7949844A0 IT7949844A0 (en) 1979-07-24
IT1118900B true IT1118900B (en) 1986-03-03

Family

ID=13986352

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49844/79A IT1118900B (en) 1978-07-25 1979-07-24 PHARMACEUTICAL COMPOSITION CONTAINING CEPHALOSPORIN FOR RECTAL ADMINISTRATION

Country Status (27)

Country Link
JP (1) JPS5517342A (en)
AU (1) AU529031B2 (en)
BE (1) BE877831A (en)
CA (1) CA1123738A (en)
CH (1) CH641351A5 (en)
CS (1) CS268651B2 (en)
DE (1) DE2929840A1 (en)
DK (1) DK159136C (en)
EG (1) EG15790A (en)
ES (1) ES482818A1 (en)
FI (1) FI792303A7 (en)
FR (1) FR2433945A1 (en)
GB (1) GB2028655B (en)
GR (1) GR69652B (en)
HU (1) HU180965B (en)
IE (1) IE48602B1 (en)
IL (1) IL57846A (en)
IN (1) IN151264B (en)
IT (1) IT1118900B (en)
LU (1) LU81546A1 (en)
NL (1) NL7905708A (en)
NO (1) NO792443L (en)
NZ (1) NZ191053A (en)
PH (1) PH16496A (en)
PT (1) PT69969A (en)
SE (1) SE7906340L (en)
ZA (1) ZA793734B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form
AT392906B (en) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmaceutical products for oral administration
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
KR100739830B1 (en) * 2001-03-23 2007-07-13 주식회사 하원제약 Method for preparing cephalosporin derivative
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
CN113637026A (en) * 2020-05-11 2021-11-12 承德医学院 Cefoperazone magnesium compound, and preparation method and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4950119A (en) * 1972-09-21 1974-05-15
JPS5538925B2 (en) * 1973-11-08 1980-10-07
GB1508071A (en) * 1976-01-19 1978-04-19 Toyama Chemical Co Ltd Cephalosporins and process for producing the same
JPS5244222A (en) * 1975-09-30 1977-04-07 Yamanouchi Pharmaceut Co Ltd Method of making insulin preparations for rectal application
JPS5822006B2 (en) * 1975-12-12 1983-05-06 萬有製薬株式会社 How to use this product
JPS6055486B2 (en) * 1976-02-28 1985-12-05 富山化学工業株式会社 Composition for rectal administration of a compound having a β-lactam ring
JPS52156918A (en) * 1976-06-21 1977-12-27 Sumitomo Chem Co Ltd Preparation of penicillin pharmaceuticals for rectal infusion
JPS5619847A (en) * 1979-07-25 1981-02-24 Hitachi Ltd Manufacturing process for discharge lamp

Also Published As

Publication number Publication date
GB2028655B (en) 1982-12-22
IL57846A (en) 1983-09-30
IE48602B1 (en) 1985-03-20
FR2433945B1 (en) 1984-12-14
GR69652B (en) 1982-07-07
AU529031B2 (en) 1983-05-26
ES482818A1 (en) 1980-09-01
BE877831A (en) 1980-01-23
PH16496A (en) 1983-10-28
JPS5517342A (en) 1980-02-06
FR2433945A1 (en) 1980-03-21
IL57846A0 (en) 1979-11-30
ZA793734B (en) 1980-07-30
IT7949844A0 (en) 1979-07-24
DE2929840C2 (en) 1989-01-12
PT69969A (en) 1979-08-01
IN151264B (en) 1983-03-19
LU81546A1 (en) 1980-01-24
CS516179A2 (en) 1989-09-12
DK310079A (en) 1980-01-26
HU180965B (en) 1983-05-30
DK159136C (en) 1991-03-11
NZ191053A (en) 1982-02-23
AU4919179A (en) 1980-01-31
SE7906340L (en) 1980-01-27
NO792443L (en) 1980-01-28
CS268651B2 (en) 1990-04-11
CH641351A5 (en) 1984-02-29
CA1123738A (en) 1982-05-18
DK159136B (en) 1990-09-10
DE2929840A1 (en) 1980-02-14
GB2028655A (en) 1980-03-12
FI792303A7 (en) 1981-01-01
NL7905708A (en) 1980-01-29
EG15790A (en) 1986-09-30
IE791411L (en) 1980-01-25

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
BE818381A (en) COMPOUNDS AND FORMULATIONS FOR DETERGENCE
BE849632A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
FR2350102A1 (en) ANALGESIC PHARMACEUTICAL COMPOSITION
DK348079A (en) ADMINISTRATION FORM
FI831534L (en) OXIKAM-DERIVAT INNEHAOLLANDE PHARMACEUTICAL COMPOSITION OCH DERAS FRAMSTAELLNINGSFOERFARANDE
SE7811637L (en) CEPHALOSPORANIC ACID DERIVATIVE, ITS PROCEDURES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
SE7711395L (en) PHARMACEUTICAL COMPOSITION
GB2020655B (en) Pharmaceutical compounds
IT1193847B (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DI-HYDRO-3-BONE-2-KINOXALINE
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
ZA773747B (en) Pharmaceutical compositions containing organic derivatives of montmorillonite
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
IT1118900B (en) PHARMACEUTICAL COMPOSITION CONTAINING CEPHALOSPORIN FOR RECTAL ADMINISTRATION
DK461579A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ARYLTRIFLUORETHANOL
FI803483L (en) MACROLIDANTIBIOTICS PHARMACEUTICAL COMPOSITION
SE7705658L (en) PHARMACEUTICAL COMPOSITION
JPS54154516A (en) Pharmaceutical composition
DE2964817D1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
NZ190958A (en) 2-phenylamino-2-imidazoline derivatives pharmaceutical compositions
JPS54147911A (en) Pharmaceutical composition containing nnacetylmulaminate glycohydrorase
IT1145416B (en) PHARMACEUTICAL COMPOSITION CONTAINING AN N4-ACYL-CITOSIN-ARABINOSIDE
RO79133A2 (en) HEPATOPROTECROBIAL MEDICINAL COMPOSITION
BE854151A (en) PHARMACEUTICAL COMPOSITION CONTAINING AMOXYCILLIN

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970521